- Home
- KZIA vs OPRX Comparison
KZIA vs OPRX Comparison
Compare KZIA & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KZIA | OPRX |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.8M | 115.4M |
| IPO Year | 2002 | 2008 |
Fundamental Metrics
Financial Performance| Metric | KZIA | OPRX |
|---|---|---|
| Price | $9.46 | $6.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $17.67 | $16.67 |
| AVG Volume (30 Days) | 139.4K | ★ 502.2K |
| Earning Date | 11-07-2025 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | N/A | $3.88 |
| Revenue Next Year | N/A | $8.49 |
| P/E Ratio | ★ N/A | $21.96 |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $2.86 | $5.54 |
| 52 Week High | $17.40 | $22.25 |
Technical Indicators
Market Signals| Indicator | KZIA | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 63.48 | 38.11 |
| Support Level | $5.64 | $5.89 |
| Resistance Level | $10.49 | $7.47 |
| Average True Range (ATR) | 0.84 | 0.48 |
| MACD | 0.17 | 0.04 |
| Stochastic Oscillator | 72.26 | 15.30 |
Price Performance
Historical ComparisonAbout KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.